BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34735650)

  • 21. Signal intensity at unenhanced T1-weighted magnetic resonance in the globus pallidus and dentate nucleus after serial administrations of a macrocyclic gadolinium-based contrast agent in children.
    Rossi Espagnet MC; Bernardi B; Pasquini L; Figà-Talamanca L; Tomà P; Napolitano A
    Pediatr Radiol; 2017 Sep; 47(10):1345-1352. PubMed ID: 28526896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
    Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
    Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
    Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
    DeBevits JJ; Munbodh R; Bageac D; Wu R; DiCamillo PA; Hu C; Wang L; Naismith RT; Karimeddini D; Dhib-Jalbut S; Redko S; Cook SD; Cadavid D; Wolansky L
    Invest Radiol; 2020 Oct; 55(10):629-635. PubMed ID: 32898355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
    Errante Y; Cirimele V; Mallio CA; Di Lazzaro V; Zobel BB; Quattrocchi CC
    Invest Radiol; 2014 Oct; 49(10):685-90. PubMed ID: 24872007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.
    Zivadinov R; Bergsland N; Hagemeier J; Ramasamy DP; Dwyer MG; Schweser F; Kolb C; Weinstock-Guttman B; Hojnacki D
    Neurology; 2019 Aug; 93(6):e611-e623. PubMed ID: 31285398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration.
    Young JR; Orosz I; Franke MA; Kim HJ; Woodworth D; Ellingson BM; Salamon N; Pope WB
    Clin Radiol; 2018 Mar; 73(3):290-295. PubMed ID: 29208312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
    Ozturk K; Nascene D
    Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
    Hu HH; Pokorney A; Towbin RB; Miller JH
    Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
    Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
    Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
    Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
    Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
    Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
    Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration.
    Tamrazi B; Nguyen B; Liu CJ; Azen CG; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 May; 287(2):452-460. PubMed ID: 29189102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging.
    Krug KB; Burke CJ; Weiss K; Baltzer PAT; Rhiem K; Maintz D; Schlamann M; Hellmich M
    Eur Radiol; 2022 Jan; 32(1):331-345. PubMed ID: 34218287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
    Ozturk K; Nascene D
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
    Kanda T; Ishii K; Kawaguchi H; Kitajima K; Takenaka D
    Radiology; 2014 Mar; 270(3):834-41. PubMed ID: 24475844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
    Kasper E; Schemuth HP; Horry S; Kinner S
    Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.